New Releases from NCBI BookshelfTarlatamab (Imdelltra): Therapeutic area: Extensive-stage small cell lung cancer: Reimbursement Review [Internet].Tarlatamab (Imdelltra): Therapeutic area: Extensive-stage small cell lung cancer: Reimbursement Review [Internet].

By admin / August 4, 2025

Post Content

New Releases from NCBI BookshelfAcalabrutinib for treating chronic lymphocytic leukaemia.Acalabrutinib for treating chronic lymphocytic leukaemia.

New Releases from NCBI BookshelfIsatuximab (Sarclisa): Indication: In combination with bortezomib, lenalidomide, and dexamethasone for the treatment of patients with newly diagnosed multiple myeloma who are not eligible for autologous stem cell transplant: Reimbursement Recommendation [Internet].Isatuximab (Sarclisa): Indication: In combination with bortezomib, lenalidomide, and dexamethasone for the treatment of patients with newly diagnosed multiple myeloma who are not eligible for autologous stem cell transplant: Reimbursement Recommendation [Internet].

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

Registration No: 771800548 Contact Number : +91-8249516996

Publication
Skill Development
Blog Writing

Research
Awareness Camp
Digital Research

Ngo Darpan
Service
Donation

Term and Condition
Privacy Policy
Disclaimer

Scroll to Top

New Releases from NCBI BookshelfTarlatamab (Imdelltra): Therapeutic area: Extensive-stage small cell lung cancer: Reimbursement Review [Internet].Tarlatamab (Imdelltra): Therapeutic area: Extensive-stage small cell lung cancer: Reimbursement Review [Internet].

Leave a Comment Cancel Reply

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.